Trial intelligence / Profile preview

Ziprasidone Sleep Architecture in Bipolar Depression

NCT00835107Phase 4Completed

Sponsor
Queen's University
Start
Feb 2009
Primary completion
Jun 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ziprasidone in bipolar disorder (BD), sponsored by Queen's University. Started Feb 2009; status: completed.

02

Drugs

ziprasidone
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00835107.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00835107.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call